Exon/intron boundaries, novel polymorphisms, and association analysis with schizophrenia of the human synaptic vesicle monoamine transporter (SVMT) gene

被引:0
作者
H Kunugi
S Ishida
A Akahane
S Nanko
机构
[1] Teikyo University School of Medicine 11–1,Department of Psychiatry
来源
Molecular Psychiatry | 2001年 / 6卷
关键词
synaptic vesicle monoamine transporter (SVMT); polymorphism; exon/intron boundaries; schizophrenia; association study;
D O I
暂无
中图分类号
学科分类号
摘要
The synaptic vesicular monoamine transporter (SVMT), alternatively vesicular monoamine transporter 2 (VMAT2), pumps cytosolic monoamines including dopamine, norepinephrine, serotonin, and histamine into synaptic vesicles. Altered functions of SVMT have been implicated in the pathogensis of several neuropsychiatric diseases. We determined exon/intron boundaries of the human SVMT gene and performed mutational analysis for the exonic and neighboring intronic regions of the gene. Detected polymorphisms were subject to association analysis with schizophrenia in a family-based design. The human SVMT gene consists, of 16 exons and 15 introns, which is consistent with the murine SVMT gene. When mutational analysis was performed by the single strand conformational polymorphism (SSCP) analysis, we found two and four single nucleotide polymorphisms (SNPs) in exons and neighboring introns, respectively. Neither exonic SNP results in an amino acid change. In family-based association analyses in a sample of 50 Japanese schizophrenics and their parents, no significant association was found for the intronic polymorphisms. Our data suggest that there is no common polymorphism in the SVMT gene affecting the primary structure of the human SVMT protein. Furthermore, we obtained no evidence for the major effect of the novel polymorphisms on susceptibility to schizophrenia.
引用
收藏
页码:456 / 460
页数:4
相关论文
共 67 条
[1]  
Iversen LL(1973)Catecholamine uptake processes Br Med Bull 29 130-135
[2]  
Edwards RH(1992)The transport of neurotransmitters into synaptic vesicles Curr Opin Neurobiol 2 586-594
[3]  
Masson J(1999)Neurotransmitter transporters in the central nervous system Pharmacol Rev 51 439-464
[4]  
Sagn C(1997)How does a vesicle know it is full? Neuron 18 683-686
[5]  
Hamon M(1954)Mental depression in hypertensive patients treated for long periods with high doses of reserpine N Engl J Med 251 1006-1008
[6]  
Mestikawy SE(1995)Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport J Neurosci 15 4102-4108
[7]  
Williams J(1994)Differences in the reserpine-sensitive storage Neurotoxicol Teratol 16 277-281
[8]  
Frize E(1994) of 1-methyl-4-phenylpyridinium in rats and mice may explain differences in catecholamine toxicity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Exp Neurol 127 54-61
[9]  
Sulzer D(1997)In brown Norway rats, MPP+ is accumulated in the nigrostriatal dopaminergic terminals but it is not neurotoxic: a model of natural resistance to MPTP toxicity Proc Natl Acad Sci USA 94 9938-9943
[10]  
Chen TK(1997)VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity Neuron 19 1285-1296